Literature DB >> 8634345

Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

S Ayesh1, Y M Shao, W D Stein.   

Abstract

We measured the effects of individual modulators and of pairs of modulators of the multidrug resistance pump, P-glycoprotein, on the accumulation of labelled daunomycin into multidrug-resistant P388 leukemia cells at 37 degrees C and developed a kinetic analysis which enables such data to be modelled in terms of co-operative, competitive or non-competitive interaction between pairs of modulators. The modulators verapamil, cyclosporin and trifluoperazine interacted with P-glycoprotein as single molecules, while vinblastine, mefloquine, dipyridamole, tamoxifen and quinidine displayed Hill numbers close to 2, suggesting that pairs of modulator molecules need to act together in order to bring about effective reversal of P-glycoprotein. When the modulators were presented to P-glycoprotein in pairs, we found examples of both competitive and non-competitive behaviour. We interpret these results on a model in which two modulatory sites exit on the MDR pump. To one of these, mefloquine, vinblastine and tamoxifen bind preferentially; to the other, verapamil, dipyridamole, trifluoperazine and quinidine bind (but mefloquine and tamoxifen only weakly if at all). Cyclosporin A can interact with both sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634345     DOI: 10.1016/0925-4439(96)00008-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Drug-lipid A interactions on the Escherichia coli ABC transporter MsbA.

Authors:  Barbara Woebking; Galya Reuter; Richard A Shilling; Saroj Velamakanni; Sanjay Shahi; Henrietta Venter; Lekshmy Balakrishnan; Hendrik W van Veen
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 3.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  The DrrAB efflux system of Streptomyces peucetius is a multidrug transporter of broad substrate specificity.

Authors:  Wen Li; Madhu Sharma; Parjit Kaur
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

5.  Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).

Authors:  U Schmitt; A Abou El-Ela; L J Guo; H Glavinas; P Krajcsi; J M Baron; C Tillmann; C Hiemke; P Langguth; S Härtter
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).

Authors:  Sascha C T Nicklisch; Amro Hamdoun
Journal:  FEBS Lett       Date:  2020-12-09       Impact factor: 4.124

7.  Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

Authors:  G Conseil; H Baubichon-Cortay; G Dayan; J M Jault; D Barron; A Di Pietro
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.

Authors:  Emily Crowley; Megan L O'Mara; Catherine Reynolds; D Peter Tieleman; Janet Storm; Ian D Kerr; Richard Callaghan
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

Review 9.  Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

Authors:  Ahmad R Safa
Journal:  Curr Med Chem Anticancer Agents       Date:  2004-01

Review 10.  Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.

Authors:  Daniel A P Gutmann; Andrew Ward; Ina L Urbatsch; Geoffrey Chang; Hendrik W van Veen
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.